《半日速报》恒指半日收报26,444点 跌54点; 恒生科技指数半日收报8,261点 升7点 药明生物(新)升逾4% 港交所、药明生物(新)、小米集团、信义光能、长汽创新高
恒指半日收26,444点,跌54点或0.2%。恒生科技指数报8,261点,升7点或0.1%。国指跌10点或0.1%,报10,472点。
活跃重磅股表现:
港交所(00388.HK) 收403.6元,上升2.4%,创新高;
美团(03690.HK) 收282元,上升1.3%;
阿里巴巴(09988.HK) 收252.6元,下跌1.2%;
腾讯(00700.HK) 收575元,下跌0.9%;
平安(02318.HK) 收93.3元,上升0.2%;
异动恒指及国指成份股:
药明生物(新)(02269.HK) 收91.45元,上升4.6%,创新高;
小米集团(01810.HK) 收30.1元,上升4.5%,创新高;
中国飞鹤(06186.HK) 收17.86元,上升4.2%;
汇控(00005.HK) 收39.5元,下跌4%;
海底捞(06862.HK) 收59.25元,上升3.7%;
翰森制药(03692.HK) 收36.8元,上升3.7%;
安踏(02020.HK) 收108.9元,上升3.6%;
中国铁塔(00788.HK) 收1.16元,下跌3.3%;
联通(00762.HK) 收4.42元,下跌3.1%;
异动综合中小型股:
百富环球(00327.HK) 收6.26元,下跌14.8%;
通达(00698.HK) 收0.6元,上升11.1%;
时代邻里(09928.HK) 收8.18元,上升11%;
信义光能(00968.HK) 收17.82元,上升10%,创新高;
长汽(02333.HK) 收20.15元,上升9.3%,创新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.